ArticlemedRxiv : the preprint server for health sciences2024
Have you heard of Rift Valley fever? Findings from a multi-country study in East and Central Africa.
Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
17 authors.
Funding
Abstract
Introduction: Rift Valley Fever (RVF) has caused outbreaks in Africa, impacting human health and animal trade. Recently, sporadic detections among humans and animals in East Africa have replaced large-scale outbreaks. We assessed RVF knowledge levels in East and Central Africa across countries with different epidemiological profiles. Materials and Methods: Individuals aged ≥10 years with acute febrile illness were enrolled from six health facilities in Kenya, Uganda, and the Democratic Republic of Congo (DRC). Sociodemographic information was collected and participants asked questions on RVF transmission, symptoms, prevention, and control. Blood samples were tested for anti-RVF antibodies (IgG and IgM). Knowledge was categorized as absent, basic, or advanced. Descriptive and ordinal logistic regression analysis identified factors associated with RVF knowledge. Results: Among 4,806 participants (median age 31, IQR 22-44, 57.5% female), only 20.5% demonstrated any RVF knowledge (16.4% basic, 4.1% advanced). Knowledge levels varied by country: DRC (3.1%), Uganda (16.1%), and Kenya (42.6%). Factors associated with RVF knowledge included age 20-40 years aOR 1.72 (95%CI 1,24-2.22) and >40 years 2.42 (95%CI 1.74-3.420), male gender aOR 1.54 (95%CI 1.31-1.82), healthcare workers aOR 7.95 (95%CI 5.25-12.1), residence in Kenya aOR 23.5 (95%CI 15.8-35.8) or Uganda 5.4 (95%CI 3.68-8.38), completing primary education aOR 3.24 (95%CI 1.94-5.75) with advanced education shown to increase knowledge, postgraduate aOR 11.5 (95%CI 4.0-32.4). Other factors included presence of livestock within the homes aOR 1.30 (95%CI 1.06-1.59) and prevention of mosquito bites aOR 1.55 (95%CI 0.46-0.66). Animal farmers, butchers, and those with close animal contact showed no association, despite being at-risk populations. Conclusion: RVF knowledge was low overall, varying by country, age, education, and environmental factors. Increased awareness is crucial for high-exposure groups in all regions, particularly in Uganda, where exposure is higher, but knowledge remains low.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.